
Monteverde & Associates Launches Inquiry into Indivior-Supernus Merger
With Indivior shareholders set to control 56.5% of the entity post-merger, the New York-based law firm Monteverde & Associates PC has initiated an investigation into the proposed combination with Supernus Pharmaceuticals. The probe seeks to determine if the deal offers fair value to existing investors before the transaction closes.
























